Vitamin K2 does appear to lower blood sugar, based on a growing body of clinical trial evidence. A recent meta-analysis of eight randomized controlled trials found that vitamin K2 supplementation significantly reduced fasting blood glucose, HbA1c (a marker of long-term blood sugar control), and insulin resistance scores. The effects are modest but consistent, and the strongest evidence comes from people with type 2 diabetes or prediabetes.
How Vitamin K2 Affects Blood Sugar
Vitamin K2 influences blood sugar through a protein called osteocalcin, which is best known for its role in bone health. Vitamin K2 activates osteocalcin by converting it from an inactive form to an active one. That activated osteocalcin then acts like a hormone, improving how sensitive your cells are to insulin. When cells respond to insulin more efficiently, they pull glucose out of your bloodstream faster, and blood sugar drops.
Interestingly, the mechanism works differently in humans than in mice. In animal studies, the inactive form of osteocalcin seemed to drive the benefit. But a placebo-controlled trial in healthy young men published in Diabetes Care showed the opposite: the activated (carboxylated) form of osteocalcin was responsible for improving insulin sensitivity. Researchers believe this activated protein may directly help skeletal muscle and fat tissue absorb glucose, or it may influence hormones produced by fat cells.
There’s also a gut connection. A six-month trial found that vitamin K2 shifted the composition of gut bacteria in people with type 2 diabetes. When researchers transplanted fecal matter from K2-supplemented mice into other mice, the recipients also showed improved glucose tolerance, suggesting the gut microbiome plays a role in how K2 improves blood sugar.
What the Clinical Trials Show
The most compelling evidence comes from a meta-analysis pooling eight randomized controlled trials. Across these studies, vitamin K supplementation produced statistically significant reductions in fasting blood glucose, a 1.0 percentage point drop in HbA1c, and meaningful improvements in insulin resistance scores (HOMA-IR). These are clinically relevant numbers, particularly the HbA1c reduction, which is comparable to what some oral diabetes medications achieve.
Individual trials reinforce these findings. In one 12-week randomized trial, 68 people with type 2 diabetes who took 360 micrograms of vitamin K2 daily (as MK-7) saw significant reductions in both fasting blood glucose and HbA1c compared to placebo. A longer six-month trial reported a 13.4% reduction in fasting glucose, a 28.3% drop in fasting insulin, and a 7.4% decrease in HbA1c.
Another eight-week study in women with polycystic ovary syndrome (a condition closely tied to insulin resistance) found that just 90 micrograms per day of MK-7 significantly reduced fasting insulin and insulin resistance while improving insulin sensitivity. HOMA-IR scores dropped from 1.71 to 1.47 in the supplement group, while the placebo group barely changed.
Effects in Prediabetes vs. Type 2 Diabetes
The meta-analysis found that vitamin K2 works through slightly different pathways depending on where you are on the blood sugar spectrum. In people with prediabetes, it improved both insulin-producing cell function and insulin resistance. In people with established type 2 diabetes, it primarily improved insulin resistance without restoring the function of insulin-producing cells. This makes sense: in later-stage diabetes, those cells are already significantly impaired and harder to rehabilitate.
MK-7 vs. MK-4: Which Form Works Better
Vitamin K2 comes in several forms, but the two you’ll encounter in supplements are MK-4 and MK-7. MK-7 has a longer half-life, better bioavailability, and higher tissue uptake than MK-4. This means it stays active in your body longer and reaches target tissues more effectively at lower doses.
Nearly all the successful human blood sugar trials used MK-7. Animal studies have shown MK-4 can also improve blood sugar markers, and lab research suggests MK-4 may uniquely inhibit fat cell formation. But for practical supplementation aimed at blood sugar, MK-7 has the stronger clinical track record. Vitamin K2 in general appears to have a more sustained effect on glucose metabolism than vitamin K1, which is the form found in leafy green vegetables.
Dosages Used in Successful Trials
The dosages that produced measurable blood sugar improvements in clinical trials ranged from 90 to 360 micrograms of MK-7 per day. The lowest effective dose studied was 90 micrograms daily for eight weeks, which improved insulin resistance in women with PCOS. The highest was 360 micrograms daily (split into two 180-microgram doses) for 12 weeks, which reduced both fasting glucose and HbA1c in people with type 2 diabetes.
Most over-the-counter vitamin K2 supplements contain between 100 and 200 micrograms of MK-7, which falls within the range used in these studies.
How Long Before You See Results
The timeline varies depending on what you’re measuring. Improvements in insulin sensitivity have appeared in as little as four weeks in healthy volunteers. The meta-analysis found that interventions shorter than 12 weeks were associated with reduced insulin resistance, suggesting relatively quick effects on how your body responds to insulin.
Changes in HbA1c take longer to show up because HbA1c reflects your average blood sugar over the previous two to three months. The 12-week trial showed HbA1c improvements by the study’s end, while the six-month trial produced more pronounced results: a 7.4% decrease in HbA1c along with a 13.4% drop in fasting glucose. If you’re tracking progress, fasting glucose may shift within a couple of months, but HbA1c will take at least three months to reflect any change.
Safety and Drug Interactions
Vitamin K2 is generally well tolerated. MK-4 has been studied at doses as high as 45 milligrams per day (far beyond what any blood sugar trial used) without causing excessive blood clotting.
The major exception is for anyone taking warfarin or similar blood-thinning medications. Vitamin K is directly involved in blood clotting, and supplementing with more than 50 micrograms of K2 per day can interfere with how well these medications work. If you take a blood thinner, your INR (a measure of clotting time) would need regular monitoring with any K2 supplementation, and your medication dose may require adjustment. This isn’t a reason to avoid K2 entirely, but it does require coordination with whoever manages your anticoagulation therapy.
Limitations of the Current Evidence
While the direction of the evidence is consistently positive, the total number of trials remains small. The most comprehensive meta-analysis included only eight studies, and the authors noted moderate quality across the data. Most trials were also relatively short, lasting three to six months. Whether the blood sugar benefits persist, plateau, or grow over longer periods is still unclear. The effect sizes, while statistically significant, are modest enough that vitamin K2 is best understood as a potential complement to diet, exercise, and any prescribed treatments rather than a standalone intervention for managing blood sugar.